FluBHPVE6E7 Immunotherapy

FluBHPVE6E7 · BlueSky Immunotherapies GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FluBHPVE6E7 Immunotherapy, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer [Phase 1]